Form 4: Climb Bio's Chief Accounting Officer, Emily Pimblett, Executes Stock Transactions

Emily Pimblett, Chief Accounting Officer of Climb Bio, executed transactions involving common stock and restricted stock units, including a sale to cover tax obligations under a pre-arranged 10b5-1 trading plan.

Summary

• On December 18, 2024, Emily Pimblett, Chief Accounting Officer of Climb Bio, converted 5,000 restricted stock units (RSUs) into common stock.
• Following this conversion, Ms. Pimblett sold 1,235 shares of common stock on December 19, 2024, at a price of $2.02 per share.
• This sale was executed under a 10b5-1 trading plan adopted on April 27, 2024, to cover tax withholding obligations related to the vesting of her RSUs.
• After these transactions, Ms. Pimblett directly owns 11,329 shares of Climb Bio common stock and 25,000 restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock transactions by an officer under a pre-arranged plan. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

This Form 4 filing is a routine disclosure related to insider trading activity, providing transparency to investors regarding the transactions of company executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the impact is likely minimal given the relatively small number of shares involved.

Key Dates